{"id":"W4400875117","doi":"10.1200/jco.23.02625","title":"Pembrolizumab Plus Carboplatin and Paclitaxel as First-Line Therapy for Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (KEYNOTE-B10): A Single-Arm Phase IV Trial","year":2024,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":55,"is_retracted":false,"has_abstract":true,"ca_institutions":"Dr. H. Bliss Murphy Cancer Centre; Kingston General Hospital; Princess Margaret Cancer Centre","funders":"National Center for Advancing Translational Sciences","keywords":"Medicine; Carboplatin; Pembrolizumab; Oncology; Paclitaxel; Head and neck; Internal medicine; Basal cell; Head and neck squamous-cell carcinoma; Phases of clinical research; Head and neck cancer; Chemotherapy; Radiation therapy; Surgery; Cancer; Immunotherapy; Cisplatin","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001955749,0.0002701222,0.002245443,0.000178721,0.0001058792,0.00003702546,0.00008951921,0.0002741102,0.00005766666],"category_scores_gemma":[0.002938656,0.0001845871,0.0004858544,0.0001509996,0.0002724916,0.000103665,0.00005000876,0.0009044422,0.000003920076],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001919835,"about_ca_system_score_gemma":0.001701771,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00003969871,"about_ca_topic_score_gemma":0.00009753102,"domain_scores_codex":[0.9964358,0.00028193,0.002214599,0.0003813352,0.0003145872,0.0003717351],"domain_scores_gemma":[0.9922608,0.006115606,0.0006802683,0.0001594251,0.0002701289,0.0005137306],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.4735808,0.007343494,0.0005502929,0.0006567219,0.00040021,0.001499734,0.00162197,0.00000261643,0.0002602386,0.00008466768,0.00795381,0.5060455],"study_design_scores_gemma":[0.4225493,0.402739,0.002833706,0.0003446278,0.0009508009,0.000804419,0.0002591514,0.001901358,0.0001106985,0.0008493037,0.166421,0.000236585],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9463513,0.04029714,0.0001142688,0.008539937,0.002669929,0.0009747815,0.00003132952,0.00001936261,0.001001918],"genre_scores_gemma":[0.9886122,0.005809717,0.001313166,0.001260602,0.002629892,0.00003336371,0.000005449858,0.00003808176,0.0002975214],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5058089,"threshold_uncertainty_score":0.7527244,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2017264981356598,"score_gpt":0.4899421537180798,"score_spread":0.2882156555824199,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}